Celon Pharma
CLN.WA
#7286
Rank
S$0.49 B
Marketcap
$9.14
Share price
-3.47%
Change (1 day)
72.07%
Change (1 year)

EPS for Celon Pharma (CLN.WA)

EPS in 2024 (TTM): -$0.14

According to Celon Pharma's latest financial reports the company's current EPS (TTM) is -$0.14. In 2023 the company made an earnings per share (EPS) of -$0.19 an increase over its 2022 EPS that were of -$0.24.

EPS history for Celon Pharma from 2015 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-$0.14-22.65%
2023-$0.19-20.64%
2022-$0.24186.32%
2021-$0.082391047.74%
2020-$0.007178-107.56%
2019$0.09500-59.53%
2018$0.237.36%
2017$0.22-18.58%
2016$0.27-5.31%
2015$0.28